# Eledon Pharmaceuticals, Inc. (ELDN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ELDN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -70.66M | $ -45.29M | $ 467.0K | $ 72.03M |
| 2025 | $ 0 | $ -46.71M | $ -63.83M | $ 641.0K | $ 81.09M |
| 2024 | $ 0 | $ -38.03M | $ -49.69M | $ 954.0K | $ 118.14M |
| 2023 | $ 0 | $ -103.87M | $ -42.74M | $ 383.0K | $ 7.21M |
| 2022 | $ 0 | $ -98.27M | $ -31.75M | $ 746.0K | $ 84.18M |
| 2021 | $ 0 | $ -41.02M | $ -34.37M | $ 769.0K | $ 164.00M |
| 2020 | $ 0 | $ -29.06M | $ -19.38M | $ 144.0K | $ 190.60M |
| 2019 | $ 0 | $ -20.67M | $ -17.89M | N/A | $ 9.47M |
| 2018 | $ 0 | $ -18.58M | $ -15.71M | N/A | $ 14.49M |
| 2017 | $ 0 | $ -17.67M | $ -20.13M | N/A | $ 19.45M |
| 2016 | $ 0 | $ -25.04M | $ -50.27M | $ 3.45M | $ 26.86M |
| 2015 | $ 0 | $ -63.30M | $ -58.69M | $ 0 | $ 61.72M |
| 2014 | $ 0 | $ -32.92M | $ -29.88M | $ 0 | $ 103.50M |
| 2013 | $ 0 | $ -12.64M | $ -13.97M | $ 0 | $ -55.27M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.75 |
| Current Ratio | 7.90 |

## Other views

- [Metrics](https://sponda.capital/en/ELDN.md)
- [Charts](https://sponda.capital/en/ELDN/charts.md)
- [Compare](https://sponda.capital/en/ELDN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.